Scientists may have finally found a way to safely restore AMPK function in humans, a milestone many researchers in the aging ...

Bio-Techne Corporation (TECH) is a global life sciences company headquartered in Minneapolis that develops, manufactures, and ...

The financing, led by The Column Group, with participation from Euclidean Capital, Samsara BioCapital, and Sanofi Ventures, will fund the development of Nura Bio’s clinical pipeline, including the ...

Bio-Techne rose 4% on a report that activist investor Ananym Capital Management has accumulated a stake in the maker of ...

A South San Francisco startup plans to use $73.8 million from high-profile investors to stay in the game to develop drugs to ...

Syntax Bio expands Series A to $14.4M to boost CRISPR Cellgorithm platform and type 1 diabetes beta-cell therapy amid tough biotech funding—read more.

This year's BIO Gives Back concert will feature global music superstar Jason Derulo as headliner, while Music Beats Cancer's Breakthrough Artists Initiative will spotlight rising performers whose ...

Syntax Bio, a synthetic biology company programming the next generation of cell therapies, today announced an expanded Series A and new appointments to its executive leadership team, board of ...

Details of Dr. Mendelsohn’s presentation are as follows: More information about the 2026 BIO International Convention can be found at https://convention.bio.org/.

View Bio-Rad Laboratories, Inc. Class A BIO stock quote prices, financial information, real-time forecasts, and company news from CNN.

If you’re a candidate for C-suite, Partner, or Board roles, you’ll be asked for a bio as part of the process. For some roles reporting to the C-suite, you may need a bio as well. Employers evaluating ...